Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?
about
Citability of original research and reviews in journals and their sponsored supplementsThe haunting of medical journals: how ghostwriting sold "HRT"Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journalsImplementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigationGhostwriting: the dirty little secret of medical publishing that just got biggerUnited States private-sector physicians and pharmaceutical contract research: a qualitative studyAre Private Interests Clouding the Peer-Review Process of the WHO Bulletin? A Case Study.Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research.Legal remedies for medical ghostwriting: imposing fraud liability on guest authors of ghostwritten articlesChallenging medical ghostwriting in US courts.Institutional mistrust in the organization of pharmaceutical clinical trials.Ghost- and guest-authored pharmaceutical industry-sponsored studies: abuse of academic integrity, the peer review system, and public trust.Knowledge of undisclosed corporate authorship ("ghostwriting") reduces the perceived credibility of antidepressant research: a randomized vignette study with experienced nurses.The economics of creative research. Research can drive economic development, but only if it is shielded from political whims and capitalist ideas.Focusing the spotlight on lack of access to health information.When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.How basic scientists help the pharmaceutical industry market drugs.The ICMJE Recommendations and pharmaceutical marketing--strengths, weaknesses and the unsolved problem of attribution in publication ethics.ICONE: An International Consortium of Neuro Endovascular Centres.The nature and influence of pharmaceutical industry involvement in asthma trials.Understanding pharmaceutical research manipulation in the context of accounting manipulation.Rooting out institutional corruption to manage inappropriate off-label drug use.Ghost and guest authors: you can't always trust who you read.Productivity of authors in the field of diabetes: bibliographic analysis of trial publicationsPublication planning: promoting an ethics of transparency and integrity in biomedical research.Big pharma and the problem of disease inflation.The spectre of ghostwriting: eroding public trust in physicians, clinical trial integrity and biomedical authorship.Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?Corruption of pharmaceutical markets: addressing the misalignment of financial incentives and public health.Industry-funded research bias and conflicts of interest.Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.Ghosts in the machine: publication planning in the medical sciences.Honorary Authorship Practices in Environmental Science Teams: Structural and Cultural Factors and Solutions."Even Heroes Get Depressed": Sponsorship and Self-Stigma in Canada's Mental Illness Awareness Week.Drug Promotion Practices: A review.Expert communities and interest-formation in the Brazilian AIDS program.Citizen expectations of 'academic entrepreneurship' in health research: public science, practical benefit.All for one or one for all? Authorship and the cross-sectoral valuation of credit in nutrition science.Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review.The Disposable Author: How Pharmaceutical Marketing Is Embraced within Medicine's Scholarly Literature.
P2860
Q21091143-68E90070-0246-4075-95AE-9B99FEC9A6CBQ21563448-67B589D5-2B87-428E-A0F8-1764DA657858Q24644642-F2D631B9-A8E3-408A-93F9-91CF8497FD55Q27498844-C941179E-E044-490A-96E4-B04E7820386DQ28119336-1651C1DF-E920-45A3-BDE6-4C1757A451C9Q28481515-BF96F6AB-C77A-4F3A-9F6C-6370D75A4203Q30386249-E9BBCBDF-1061-4CF1-8A01-9BC95C6EB877Q33807895-A0CF3A45-0C79-4B0F-973C-FB0B85B85E19Q33987346-3DE45450-ED23-4ED3-BFB6-58937A623185Q34145613-3AC41F4C-CB76-484C-AE90-92E70E0AAED3Q34186875-5E630ABB-C821-45F0-B16A-3416DB8FFB38Q34339237-E0910F06-A74D-451E-BF95-D9806734BA75Q34403714-F98FF6E8-58B4-4D32-8D44-0034E61D8859Q34580663-F3EA53D4-52E1-4D8F-B2C9-97E1F8931403Q34699642-291B99E2-6F0E-4DB1-94D0-46B07C811164Q34828582-0B647B6E-823B-4C48-8129-006C1A6E5886Q35047976-AD75BBBC-580A-4CC8-842C-B2E804B87136Q36765612-EDE55EF2-099B-4E5C-84CF-6F7414ED5E57Q37765956-2670D528-46E3-4DB9-A870-9F943A9D3CDEQ38034512-8EEB9F9F-2C0D-4620-BDCB-98788D99601DQ38148607-DF20A9A4-F671-4EAC-AE94-7998A68F42EBQ38148609-56F03E41-CF7A-4572-8B12-36B72943D398Q38262033-B7A6E753-ECC0-4D6B-A6FB-BE81939E4156Q38542019-7E1C27F0-5C63-4EF9-95F8-E45834CDAEE9Q38574643-1102403B-FD44-48FA-ABE3-F3D02D675DDDQ39177221-9C1498AC-8446-49E8-B9DF-9F69515A4959Q39647337-B3ECF92F-C78B-49D8-A108-6610832F67C4Q42540847-4BE23288-9D9A-4FBB-B1FD-4D34857FD01EQ43409220-E502AA2B-EA2B-4DB5-81D8-0503E04FB906Q43597538-DA98A779-92EC-47E2-A165-91D41F702439Q43757409-28EF192C-F2E5-4112-9595-C8C943C3C1CDQ43768493-90B81E95-EAA4-44CC-A845-066D40048744Q47388083-0E2512DB-925B-4524-AACF-D3A2644DDBE2Q47598382-676554CF-0BFD-4C83-8A0F-3704EF21D310Q47724203-ADCC3368-9B1C-4817-80C0-84E04A223B5AQ47857815-AF552A80-5F45-4C50-B55C-282A42C3DEF4Q48076527-F1274E3C-B761-4B9D-99B8-28429AFC1596Q48182850-2BAAB137-1508-457F-B64A-D651E2B9CE15Q50133431-999D3AA0-A89E-4436-BCBF-E3B4A3A59F0DQ53042847-9A3F856E-091D-4DBF-BE40-A7700B654BA3
P2860
Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Ghost management: how much of ...... y the pharmaceutical industry?
@ast
Ghost management: how much of ...... y the pharmaceutical industry?
@en
Ghost management: how much of ...... y the pharmaceutical industry?
@en-gb
Ghost management: how much of ...... y the pharmaceutical industry?
@nl
type
label
Ghost management: how much of ...... y the pharmaceutical industry?
@ast
Ghost management: how much of ...... y the pharmaceutical industry?
@en
Ghost management: how much of ...... y the pharmaceutical industry?
@en-gb
Ghost management: how much of ...... y the pharmaceutical industry?
@nl
altLabel
Ghost Management: How Much of ...... y the Pharmaceutical Industry?
@en
prefLabel
Ghost management: how much of ...... y the pharmaceutical industry?
@ast
Ghost management: how much of ...... y the pharmaceutical industry?
@en
Ghost management: how much of ...... y the pharmaceutical industry?
@en-gb
Ghost management: how much of ...... y the pharmaceutical industry?
@nl
P2860
P3181
P1433
P1476
Ghost management: how much of ...... y the pharmaceutical industry?
@en
P2093
Sergio Sismondo
P2860
P3181
P356
10.1371/JOURNAL.PMED.0040286
P407
P577
2007-09-01T00:00:00Z